327 related articles for article (PubMed ID: 32166483)
1. Pharmaceutical care recommendations for antiviral treatments in children with coronavirus disease 2019.
Wang Y; Zhu LQ
World J Pediatr; 2020 Jun; 16(3):271-274. PubMed ID: 32166483
[No Abstract] [Full Text] [Related]
2. Infection of severe acute respiratory syndrome coronavirus 2 in a patient with AIDS.
Su J; Shen X; Ni Q; Zhao H; Cai J; Zhu B; Wu W; Lang G; Xu K; Sheng J
AIDS; 2020 Aug; 34(10):1575-1576. PubMed ID: 32675569
[No Abstract] [Full Text] [Related]
3. A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option.
Yao TT; Qian JD; Zhu WY; Wang Y; Wang GQ
J Med Virol; 2020 Jun; 92(6):556-563. PubMed ID: 32104907
[TBL] [Abstract][Full Text] [Related]
4. Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol.
Zeng YM; Xu XL; He XQ; Tang SQ; Li Y; Huang YQ; Harypursat V; Chen YK
Chin Med J (Engl); 2020 May; 133(9):1132-1134. PubMed ID: 32149772
[No Abstract] [Full Text] [Related]
5. Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients.
Wang N; Zhan Y; Zhu L; Hou Z; Liu F; Song P; Qiu F; Wang X; Zou X; Wan D; Qian X; Wang S; Guo Y; Yu H; Cui M; Tong G; Xu Y; Zheng Z; Lu Y; Hong P
Cell Host Microbe; 2020 Sep; 28(3):455-464.e2. PubMed ID: 32707096
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA
Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849
[TBL] [Abstract][Full Text] [Related]
7. Discontinuation of antiviral drugs may be the reason for recovered COVID-19 patients testing positive again.
Wu F; Zhang W; Zhang L; Wang D; Wan Y
Br J Hosp Med (Lond); 2020 Apr; 81(4):1-2. PubMed ID: 32339007
[No Abstract] [Full Text] [Related]
8. Take precautions beforehand: calling for clinical trials of pediatric drugs for treating coronavirus disease 2019.
Ni SQ; Fu QB; Shou XY; Shu Q
World J Pediatr; 2020 Jun; 16(3):275-277. PubMed ID: 32215827
[No Abstract] [Full Text] [Related]
9. Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.
Bimonte S; Crispo A; Amore A; Celentano E; Cuomo A; Cascella M
In Vivo; 2020 Jun; 34(3 Suppl):1597-1602. PubMed ID: 32503817
[TBL] [Abstract][Full Text] [Related]
10. Exploring an Integrative Therapy for Treating COVID-19: A Randomized Controlled Trial.
Wang JB; Wang ZX; Jing J; Zhao P; Dong JH; Zhou YF; Yang G; Niu M; Zhao X; Jiang TJ; Bi JF; Xu Z; Zhang P; Wu D; Bai ZF; Guo YM; Yu SM; Sun YQ; Zhang ZT; Zhan XY; Li PY; Ding JB; Zhao PF; Song XA; Tang JY; He DC; Chen Z; Qin EQ; Wang RL; Xiao XH
Chin J Integr Med; 2020 Sep; 26(9):648-655. PubMed ID: 32676976
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of 2019 novel coronavirus infection in children: a pressing issue.
Shen KL; Yang YH
World J Pediatr; 2020 Jun; 16(3):219-221. PubMed ID: 32026147
[No Abstract] [Full Text] [Related]
12. Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019.
Barlow A; Landolf KM; Barlow B; Yeung SYA; Heavner JJ; Claassen CW; Heavner MS
Pharmacotherapy; 2020 May; 40(5):416-437. PubMed ID: 32259313
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic and sonodynamic therapy of acute hypoxemic respiratory failure in patients with COVID-19.
Kipshidze N; Yeo N; Kipshidze N
Photodiagnosis Photodyn Ther; 2020 Sep; 31():101961. PubMed ID: 32818638
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous small-vessel vasculitis associated with novel 2019 coronavirus SARS-CoV-2 infection (COVID-19).
Dominguez-Santas M; Diaz-Guimaraens B; Garcia Abellas P; Moreno-Garcia Del Real C; Burgos-Blasco P; Suarez-Valle A
J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):e536-e537. PubMed ID: 32453865
[No Abstract] [Full Text] [Related]
15. Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis.
Liu W; Zhou P; Chen K; Ye Z; Liu F; Li X; He N; Wu Z; Zhang Q; Gong X; Tang Q; Du X; Ying Y; Xu X; Zhang Y; Liu J; Li Y; Shen N; Couban RJ; Ibrahim QI; Guyatt G; Zhai S
CMAJ; 2020 Jul; 192(27):E734-E744. PubMed ID: 32493740
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 presenting with diarrhoea and hyponatraemia.
Ata F; Almasri H; Sajid J; Yousaf Z
BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32513768
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 in Children: Clinical Approach and Management.
Sankar J; Dhochak N; Kabra SK; Lodha R
Indian J Pediatr; 2020 Jun; 87(6):433-442. PubMed ID: 32338347
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern?
Marmor MF
Am J Ophthalmol; 2020 May; 213():A3-A4. PubMed ID: 32247518
[No Abstract] [Full Text] [Related]
19. COVID-19 and Chloroquine/Hydroxychloroquine: Is There Ophthalmological Concern?
Marmor MF
Am J Ophthalmol; 2020 Aug; 216():A1-A2. PubMed ID: 32439074
[No Abstract] [Full Text] [Related]
20. Just the facts: What drugs are safe and effective for COVID-19?
Long B; Liang SY; Rosenberg H; Hicks C; Gottlieb M
CJEM; 2020 Sep; 22(5):591-594. PubMed ID: 32438948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
